A new Northwestern Medicine study published in the Proceedings of the National Academy of Sciences has explored the impacts ...

ATTR-CM treatment options narrowed after AstraZeneca and Ionis revealed their gene-silencing drug Wainua (eplontersen) failed ...

Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...

The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...

The expanding interest in small bioactive peptides has brought renewed attention to glycyl-L-histidyl-L-lysine bound to ...

Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Scientists with the World Wildlife Fund started a turtle DNA database that is helping with efforts to protect and keep several species from extinction. NBC News' George Solis shows how it works and ...

All Evaluable Patients Achieved Improvements in Multiple Hallmarks of MYBPC3-Associated HCM Benefits Among Cohort 1 Patients Sustained as Far Out ...